Selling a life insurance policy with lung cancer
Key facts about viatical settlements for lung cancer patients.
At a glance
- Typical payout40-70% of face value
- Best fitStage III/IV often qualifies
- Tax treatmentOften tax-free under §101(g)
- Timeline30-60 days to funds
- EligibilityPolicy ≥ $100K, 2+ years old
What patients with lung cancer should know
For lung cancer patients, selling an existing policy can turn an asset that might otherwise lapse, surrender, or become unaffordable into immediate cash. Many patients receive substantially more than the policy’s cash surrender value.
Stage III/IV diagnoses often qualify, because life-expectancy projections are shorter. These cases frequently qualify for a viatical settlement under IRS §101(g), which is often tax-free at the federal level when certified by a physician. Many cases close in 30-60 days.
How payout ranges work
On a $500,000 policy, a patient with lung cancer might receive between 40 and 70% of the face value, depending on stage, treatment trajectory, age, policy type, and carrier. That’s between $200,000 and $350,000 in cash, often delivered in 30-60 days from acceptance. Most patients receive substantially more than the policy’s cash surrender value.
What we’d recommend asking
- What’s the difference between a life settlement and a viatical settlement for my diagnosis?
- How will this affect my Medicaid eligibility?
- What documentation does the buyer need from my oncologist?
- Is there a rescission window if I change my mind?
- Are there better alternatives (policy loan, accelerated death benefit rider)?
Related resources
See what your policy is worth.
Thirty seconds to find out. No medical records, no credit check, no cost.